Loading stock data...

Ishita Drugs and Industries Limited

BSE: ISHITADR

BSE
75.99 1.49 (2.00%)

Prev Close

74.5

Open Price

76.6

Volume

186

Today Low / High

75.99 / 76.6

52 WK Low / High

62.35 / 99.64

Range

72 - 80

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 75.99, reflecting a change of 1.49 (2%). The expected target range on the BSE is 72 - 80. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

22 Aug 76.60 -0.80%
21 Aug 74.08 0.57%
20 Aug 75.50 -1.88%
18 Aug 77.60 -2.38%
14 Aug 73.16 6.59%
13 Aug 76.90 -1.50%
12 Aug 70.76 6.90%
11 Aug 72.90 -2.95%
08 Aug 74.00 -2.70%
07 Aug 75.00 -1.35%
06 Aug 78.80 -6.61%
05 Aug 78.00 0.00%
04 Aug 77.80 0.99%
31 Jul 78.80 -0.25%
30 Jul 78.80 -0.44%
29 Jul 75.00 5.05%
28 Jul 78.90 -4.52%

Ishita Drugs and Industries Limited Graph

Ishita Drugs and Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Ishita Drugs and Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 75.99, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 75.99 76.75 69.07 - 84.42
77.51 62.01 - 93.01
78.27 54.79 - 101.75
Bearish Scenario 75.99 75.23 67.71 - 82.75
74.47 59.58 - 89.36
73.71 51.60 - 95.82

Overview of Ishita Drugs and Industries Limited

ISIN

INE806D01016

Industry

Medical - Pharmaceuticals

Vol.Avg

1,589

Market Cap

227,232,897

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

124.48

DCF

-47

Financial Ratios Every Investor Needs

Stock Rating Details for ISHITADR

Metric Value Recommendation
Overall Rating B- Neutral
DCF Score 1 Strong Sell
ROE Score 4 Buy
ROA Score 4 Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 15.00 Cr 10.68 Cr 2.86 Cr 0.1908 0.00 Cr 0.00 Cr 0.89 Cr 0.87 Cr 2.92 1.34 Cr 0.0579
2024-03-31 15.19 Cr 11.71 Cr 3.48 Cr 0.2288 0.00 Cr 0.46 Cr 0.80 Cr 0.75 Cr 2.50 1.19 Cr 0.0493
2023-03-31 12.07 Cr 9.00 Cr 3.07 Cr 0.2546 0.02 Cr 0.37 Cr 0.63 Cr 0.58 Cr 1.93 0.96 Cr 0.0478
2022-03-31 14.09 Cr 10.71 Cr 3.38 Cr 0.2396 0.02 Cr 0.50 Cr 0.96 Cr 0.80 Cr 2.69 1.20 Cr 0.0571
2021-03-31 13.95 Cr 10.90 Cr 3.05 Cr 0.2183 0.02 Cr 0.39 Cr 0.77 Cr 0.83 Cr 2.77 1.23 Cr 0.0595

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.57 Cr 16.30 Cr 5.51 Cr 10.7896 Cr 3.90 Cr 3.33 Cr 4.46 Cr 0.88 Cr 0.00 Cr 0.00 Cr 0.43 Cr 5.4048 Cr
2024-03-31 1.83 Cr 10.81 Cr 0.89 Cr 9.9215 Cr 0.00 Cr -1.83 Cr 1.06 Cr 0.80 Cr 0.00 Cr 0.00 Cr -2.64 Cr 0.8673 Cr
2023-03-31 0.61 Cr 11.41 Cr 2.23 Cr 9.1730 Cr 0.96 Cr 0.35 Cr 1.60 Cr 0.89 Cr 0.00 Cr 0.00 Cr -5.67 Cr 2.2130 Cr
2022-03-31 1.99 Cr 11.25 Cr 2.66 Cr 8.5956 Cr 0.00 Cr -1.99 Cr 0.97 Cr 0.88 Cr 0.00 Cr 0.00 Cr 0.27 Cr 2.6292 Cr
2021-03-31 1.75 Cr 9.26 Cr 1.47 Cr 7.7907 Cr 0.04 Cr -1.71 Cr 0.65 Cr 1.00 Cr 0.00 Cr 0.00 Cr 0.23 Cr 1.4332 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -3.6371 Cr -0.6663 Cr 4.3274 Cr -3.8213 Cr 0.0240 Cr 4.8338 Cr -0.1842 Cr 1.1551 Cr 4.1151 Cr 0.0000 Cr -3.4007 Cr
2024-03-31 2.1208 Cr 0.1303 Cr -0.8695 Cr 2.0940 Cr 1.3815 Cr 4.8098 Cr -0.0268 Cr 0.9873 Cr -0.9604 Cr 0.0000 Cr 0.5341 Cr
2023-03-31 -2.8975 Cr 0.5942 Cr 1.0497 Cr -3.0316 Cr -1.2536 Cr 3.4283 Cr -0.1342 Cr 0.7794 Cr 0.9604 Cr 0.0000 Cr -0.6246 Cr
2022-03-31 3.0763 Cr -0.9344 Cr 0.0017 Cr 3.0578 Cr 2.1436 Cr 4.6819 Cr -0.0185 Cr 1.0430 Cr -0.0419 Cr 0.0000 Cr -0.3193 Cr
2021-03-31 -0.6748 Cr 2.4509 Cr -0.2374 Cr -0.6797 Cr 1.5387 Cr 2.5383 Cr -0.0049 Cr 1.0537 Cr -0.2461 Cr 0.0000 Cr -0.0735 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 4.56 Cr 3.57 Cr 1.00 Cr 0.2181 0.27 Cr 0.29 Cr 0.97 0.45 Cr 0.0631
2024-12-31 4.13 Cr 2.80 Cr 1.33 Cr 0.3214 0.27 Cr 0.24 Cr 0.80 0.36 Cr 0.0576
2024-09-30 3.27 Cr 2.23 Cr 1.04 Cr 0.3177 0.21 Cr 0.19 Cr 0.65 0.29 Cr 0.0595
2024-06-30 3.03 Cr 2.45 Cr 0.58 Cr 0.1916 0.15 Cr 0.15 Cr 0.49 0.23 Cr 0.0487
2024-03-31 4.50 Cr 3.87 Cr 0.63 Cr 0.1396 0.28 Cr 0.28 Cr 0.94 0.40 Cr 0.0627

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.57 Cr 7.81 Cr 8.38 Cr 2.14 Cr 4.46 Cr 14.98 Cr 0.88 Cr 16.30 Cr 5.51 Cr
2024-12-31 0.00 Cr 0.00 Cr 10.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -10.26 Cr
2024-09-30 3.23 Cr 7.37 Cr 10.60 Cr 0.00 Cr 1.56 Cr 13.81 Cr 0.73 Cr 14.95 Cr 4.69 Cr
2024-06-30 0.00 Cr 0.00 Cr 7.87 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -9.92 Cr
2024-03-31 1.83 Cr 6.05 Cr 7.87 Cr 0.00 Cr 1.06 Cr 9.66 Cr 0.80 Cr 10.81 Cr 0.89 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 0.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.19 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 0.12 Cr 0.07 Cr 0.00 Cr 0.00 Cr 0.07 Cr 1.97 Cr 1.91 Cr 0.00 Cr 0.07 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹821.25 ₹98,339,283,675.00 ₹72,992.00

Key Executives

Head of Operations
Mr. Kiran Rindani

Gender: male

Year Born:

Company Secretary & Compliance Officer
Ms. Srushti Pandya

Gender: female

Year Born: 1993

Chairman & MD
Mr. Jagdishprasad G. Agrawal

Gender: male

Year Born:

Chief Financial Officer
Mr. Sumit J. Agrawal

Gender: male

Year Born: 1973

FAQs about Ishita Drugs and Industries Limited

Who is the CEO of the company?

The CEO is Jagdishprasad G. Agrawal.

What is the current market price of the stock?

The current price is ₹75.99.

What is the 52-week price range?

The range is ₹62.35-99.64.

What is the market capitalization of the company?

The market capitalization is ₹22.72 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 26.04.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Ishita Drugs and Industries Limited (ISIN: INE806D01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹22.72 crores and an average daily volume of 1,589 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack